Annexon: Breakthrough In Guillain-Barré Faces Upcoming FDA Hurdles

Annexon: Breakthrough In Guillain-Barré Faces Upcoming FDA Hurdles #Annexon #Breakthrough #GuillainBarré #Faces #Upcoming #FDA #Hurdles

FDA grants breakthrough status to GSK cancer drug By Investing.com

LONDON – GSK plc (LSE/NYSE: GSK) has received Breakthrough Therapy Designation from the US Food and…

Nasdaq extension, new tech collaboration, and FDA approval set tone for pre-market

& CEIFX Good day, 360! HEADS UP:  JW is having an Open House TODAY in Market…

Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It Lasted

Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It…

US FDA warns online vendors selling unapproved weight-loss drugs By Reuters

(Reuters) – The U.S. Food and Drug Administration said on Tuesday it has sent warning letters…